Calanolide A
Calanolide A is a naturally occurring non-nucleoside reverse transcriptase inhibitor (NNRTI) derived from the Calophyllum tree species. It was first discovered in the 1990s during a large-scale screening of plant extracts for anti-HIV activity. Calanolide A has been the subject of extensive research due to its potential use in the treatment of HIV/AIDS.
History
Calanolide A was first isolated from the Calophyllum lanigerum tree in Sarawak, Malaysia, as part of a United States National Cancer Institute (NCI) program that aimed to identify potential anti-HIV compounds from natural sources. The compound was found to have significant anti-HIV activity, leading to further research and development.
Structure and Properties
Calanolide A is a dipyranocoumarin, a type of coumarin derivative. It has a complex structure that includes a lactone ring and a pyran ring. The compound is chiral, meaning it has a non-superimposable mirror image. The stereochemistry of Calanolide A is important for its anti-HIV activity.
Mechanism of Action
Calanolide A acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI). Reverse transcriptase is an enzyme that HIV uses to replicate its genetic material. By inhibiting this enzyme, Calanolide A prevents the virus from replicating and spreading to new cells.
Clinical Development
The clinical development of Calanolide A has involved preclinical studies, phase I clinical trials, and phase II clinical trials. These studies have shown that Calanolide A has a good safety profile and is effective in reducing HIV viral load in patients. However, the development of drug resistance is a potential concern.
Future Prospects
While Calanolide A has shown promise as an anti-HIV drug, further research is needed to fully understand its potential benefits and risks. The development of new formulations and combination therapies may help to overcome some of the challenges associated with this compound.
This HIV related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
